In our earlier studies we placed greater emphasis on organ differences in capillary transit time and, while these are important, subsequent studies have illuminated the importance of organ differences in rates of hormone dissociation from the binding protein in vivo within the microcirculation.
(3) It states that we should assume dissociation from the binding protein is infinitely rapid. This statement is misleading and false and, in fact, the assumption we have employed is that either hormone dissociation or hormone reassociation with the binding protein is fast relative to the rate of hormone transport through the microvascular membrane.' Indeed, our model is applicable if hormone dissociation is slow relative to the rate of transport through the membrane as long as hormone reassociation with the binding protein is fast relative to membrane transport. Since rates of hormone reassociation with albumin are of a log order rather than the rates of hormone transport through microvascular membranes, the modified Kety-Renkin-Crone equation used in our studies is valid.' (4) It states that an enhanced dissociation mechanism operating on albumin alone would merely cause the hormone so released to immediately re-bind to the serum binding globulin. This statement ignores our experimental work using numerical analysis and fitting experimentally observed testosterone extraction data to that predicted by a model allowing for enhanced dissociation from albumin and not from SHBG. Ekins is referred to Figure 2 of Pardridge and Landac'' for further insight into this area.
(5) Again, it states that there is no basis for supposing as do Blight et al.' that non-SHBGbound testosterone might provide a more appropriate biochemical parameter for the study of hirsutism than that provided by measurements of free testosterone. Ekins is referred to the study of salivary testosterone in hirsutism showing that the ratio of salivary testosterone to total plasma testosterone is 10·3% in these patients," which is nearly IO-fold greater than the percentage of free testosterone measured in vitro but approximates the bioavailable testosterone in salivary gland capillaries in vivo? Thus, bioavailable testosterone in humans is a function of the non-SHBGbound testosterone, not free testosterone.
(6) Ekins and other proponents" of the free hormone hypothesis are forced to postulate, (a) dissociation-limited models of hormone transport in vivo that have no experimental support and (b) the existence of active pumps for hormone at the nuclear membrane that have never been identified. Such postulates are necessary to explain away the conflict that nuclear free hormone concentrations are log orders greater than free hormone measured in vitro, but approximate to the concentration of albuminbound hormone." 
Total amylase and pancreatic isoamylase in serum and urine
The values presented by Cummings and Fraser' for total amylase, pancreatic rsoamylase, amylase/creatinine ratio and pancreatic sioamylase/creatinine ratio in urine samples are considerably lower than those obtained by us and by others using a similar method.' Their finding of a lower mean pancreatic isoamylase/ amylase ratio in urine than in serum (albeit from different subjects) is surprising; in normal subjects, pancreatic isoamylase has a higher renal clearance than salivary isoamylase (which forms the remainder of the total amylase activity) and the pancreatic isoamylase/amylase ratio should thus be higher in the urine than in the serum."? Using the same methods as Cummings and Fraser (total a-Amylase EPS and Pancreatic (X-Amylase EPS, BCL, Lewes, East Sussex, performed at 37°C, inter-assay CV 3·0-4·5%) we have found this to be the case in urine and serum samples from 46 normal subjects (mean PjT ratio inurine = 0·75, mean PjT ratio in serum = 0'51, samples stored at 4°C for a maximum of 72 hours before assay).
We have observed a reduction in amylase activity in some urine specimens on even short term storage at -20°C; instability of amylase in frozen urine has also been noted by others.' The period of storage of urine at -20°C was not stated by Cummings and Fraser but, because of the design of their study, it must have exceeded 10 weeks for some samples. In order to examine the possibility that loss of amylase activity may occur during frozen storage of samples, we performed a small study. Nine healthy subjects, aged 24-53 years, provided fasting serum samples, first morning urine samples and random urine samples on the same day. Aliquots from each sample were analysed for amylase and pancreatic isoamylase: (i) on the day of collection having been kept at room temperature; (ii) after storage for 14 days at 4°C; and (iii) after storage for 14 days at -20°e. The results for urine samples are summarised in Table 1 together with results obtained by Cummings and Fraser.' Serum amylase and pancreatic isoamylase activities did not change significantly with either method of storage. Urine amylase and pancreatic isoamylase were not affected by storage at 4°C for 14 days (all activities were between 99-109% of original values, mean 104'2%). There was a mean loss of 10·8% of amylase and 11·1% of panreatic isoamylase in the urines that had been frozen. This loss of activity was variable with one sample losing 31% of both total amylase and pancreatic isoamylase. Loss of amylase and pancreatic isoamylase activity occurring over a longer period of frozen storage of urine samples could account for the large discrepancy between our results and those of Cummings and Fraser.
We recommend that urine for amylase analysis should not be frozen. 
